Pseudotumor cerebri: An update on treatment options

Pseudotumor Cerebri (Idiopathic Intracranial Hypertension) an Update

1.1 History Historically, several terms have been used to depict pseudotumor cerebri (PTC). In the late 1890's, Quincke (1893, 1897) was the first to describe and name this syndrome "meningitis serosa" patients suffering from headache, impaired visual acuity and papilledema. He related the symptoms to a state of elevated intracranial pressure and presumed it was caused by increased secretion of...

Update on Pseudotumor Cerebri (Idiopathic Intracranial Hypertension)

In 1904 the German neurologist Max Nonne introduced the term pseudotumor cerebri (PTC) to describe the clinical syndrome of chronically elevated intracranial pressure of unknown etiology. As diagnostic options grew broader and more effective over time, however, numerous pathological conditions that can cause chronically high intracranial pressure were identified, which occasioned its classifica...

Pseudo-pseudotumor cerebri.

An update on the pathophysiology of idiopathic intracranial hypertension alias pseudotumor cerebri.

Idiopathic intracranial hypertension (IIH) is a syndrome characterized by increased intracranial pressure of unknown cause, leading to severe headache, papilledema and visual disturbances. Its former name, pseudotumor cerebri, has gained popularity recently. The strongest and most consistent risk factors of IIH are obesity and female gender. Infrequently, IIH may present in the absence of papil...

Pseudotumor cerebri: a review.

Pseudotumor cerebri (PTC) is a syndrome seen more frequently in young, obese women defined by increased intracranial pressure without obstruction of the ventricular system. Normal neurodiagnostic studies, normal cerebrospinal fluid (CSF) contents, papilledema in one or both eyes, and normal mental status should also be recognized. Although the disorder has been associated with drugs, endocrinop...